Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Emotional Distress

Tuesday, December 16, 2014
Emotional distress has long been associated with a cancer diagnosis and cancer treatment. However, the prevalence of emotional distress and related psychosocial effects, such as depression and anxiety, have not been fully studied. Researchers in Germany reported that 32% of 2,141 patients with cancer interviewed at inpatient and outpatient care centers experienced a clinically meaningful level of mental or emotional distress that met the strict diagnostic criteria for mental disorders, which included anxiety, depressive and adjustment disorders. The highest prevalence was found among patients with breast cancer (42%) and head and neck cancer (41%), followed by malignant melanoma (39%). The lowest prevalence was found among patients with prostate cancer (22%), stomach cancer (21%), and pancreatic cancer (20%). This study is notable in that it is a large study that used fully standardized, diagnostic face-to-face interviews to assess emotional distress.

In the four-week period prior to the interview, 11.5% of patients experienced an anxiety disorder, 11% met the criteria for an adjustment disorder, and 6.5% had signs of a mood disorder. The 11.5% rate of anxiety disorders, such phobia, panic or generalized anxiety disorder, was slightly higher than in the general population (9%), while the prevalence of other mental health diagnoses was similar to rates in the general population. The researchers noted that it was surprising that patients with a more treatable cancer, such as breast cancer, experienced more distress than people with cancers that are more challenging to treat, such as stomach and pancreatic cancer, and that more research is needed to interpret these findings.

Mehnert A et al. Four-Week Prevalence of Mental Disorders in Patients with Cancer Across Major Tumor Entities. Journal of Clinical Oncology. Published online before print October 6, 2014, doi:10.1200/JCO.2014.56.0086

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.